Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-24-194954
Filing Date
2024-08-06
Accepted
2024-08-06 16:52:10
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d859046d424b5.htm 424B5 390391
2 GRAPHIC g859046g13e11.jpg GRAPHIC 76298
  Complete submission text file 0001193125-24-194954.txt   496773
Mailing Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210
Business Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210 857-330-4340
Inozyme Pharma, Inc. (Filer) CIK: 0001693011 (see all company filings)

EIN.: 475129768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-275364 | Film No.: 241180187
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)